(Q43521275)

24 November 2017

title

Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma (English)

1 reference

24 November 2017

0 references

Yuxia Han

1

1 reference

24 November 2017

Wenxia Zhang

series ordinal

2

1 reference

24 November 2017

Yanfeng Liu

series ordinal

3

1 reference

24 November 2017

publication date

1 October 2013

1 reference

24 November 2017

published in

World Journal of Surgery

1 reference

24 November 2017

volume

37

1 reference

24 November 2017

issue

10

1 reference

24 November 2017

page(s)

2419-2427

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

24 November 2017

1 reference

Surgical management of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Partial purification and characterization of human hepatoma-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Expression of hepatoma-derived growth factor in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

shRNA targeting HDGF suppressed cell growth and invasion of squamous cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Expression of hepatoma‐derived growth factor in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Hepatoma-derived growth factor and its role in keloid pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Development and clinical evaluation of a multi-purpose mAb and a sandwich ELISA test for hepatoma-derived growth factor in lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2132-4

Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma

1 reference

12 December 2020

Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein

1 reference

12 December 2020

Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature.

1 reference

12 December 2020

Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma

1 reference

12 December 2020

Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma

1 reference

12 December 2020

10.1007/S00268-013-2132-4

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1051794739

0 references

1 reference